IL96942A - תערובת רוקחית המכיליה תולדות אמיד מונע רנין - Google Patents

תערובת רוקחית המכיליה תולדות אמיד מונע רנין

Info

Publication number
IL96942A
IL96942A IL9694291A IL9694291A IL96942A IL 96942 A IL96942 A IL 96942A IL 9694291 A IL9694291 A IL 9694291A IL 9694291 A IL9694291 A IL 9694291A IL 96942 A IL96942 A IL 96942A
Authority
IL
Israel
Prior art keywords
amino
alkyl
loweralkyi
alkylamino
loweralkyl
Prior art date
Application number
IL9694291A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL96942A publication Critical patent/IL96942A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/553—Renin inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
IL9694291A 1990-01-31 1991-01-14 תערובת רוקחית המכיליה תולדות אמיד מונע רנין IL96942A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47293790A 1990-01-31 1990-01-31
US63259591A 1991-01-04 1991-01-04

Publications (1)

Publication Number Publication Date
IL96942A true IL96942A (he) 1995-01-24

Family

ID=27043970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9694291A IL96942A (he) 1990-01-31 1991-01-14 תערובת רוקחית המכיליה תולדות אמיד מונע רנין

Country Status (8)

Country Link
EP (1) EP0440102A1 (he)
JP (1) JPH06107562A (he)
KR (1) KR910014115A (he)
AU (1) AU632895B2 (he)
CA (1) CA2035163A1 (he)
IE (1) IE910320A1 (he)
IL (1) IL96942A (he)
PT (1) PT96610A (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA921381B (en) * 1991-03-01 1992-11-25 Fujisawa Pharmaceutical Co New use of amino acid derivatives
KR100849880B1 (ko) * 2001-12-20 2008-08-01 주식회사 중외제약 광학활성 2-[6-(치환된 알킬)-1,3-디옥산-4-일]아세트산유도체의 신규 제조 방법
AU2004293178B8 (en) * 2003-11-26 2009-01-08 Novartis Ag Organic compounds
GB0327839D0 (en) * 2003-12-01 2003-12-31 Novartis Ag Organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837204A (en) * 1985-01-23 1989-06-06 Abbott Laboratories Functionalized peptidyl aminodiols and -triols
US4845079A (en) * 1985-01-23 1989-07-04 Luly Jay R Peptidylaminodiols
DK34086A (da) * 1985-01-23 1986-07-24 Abbott Lab Peptidylaminodioler
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
US4851387A (en) * 1986-10-14 1989-07-25 Banyu Pharmaceutical Co., Ltd. 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use
US5032577A (en) * 1986-12-31 1991-07-16 Abbott Laboratories Peptidylaminodiols
IL87614A0 (en) * 1987-09-16 1989-01-31 Abbott Lab Peptidylheterocycles
IL90184A0 (en) * 1988-05-09 1989-12-15 Abbott Lab Functionalized peptidyl aminodiols and-triols

Also Published As

Publication number Publication date
PT96610A (pt) 1991-12-31
JPH06107562A (ja) 1994-04-19
AU6987891A (en) 1991-08-01
CA2035163A1 (en) 1991-08-01
EP0440102A1 (en) 1991-08-07
IE910320A1 (en) 1991-07-31
AU632895B2 (en) 1993-01-14
KR910014115A (ko) 1991-08-31

Similar Documents

Publication Publication Date Title
US5122514A (en) Psoriasis treatment
US5063208A (en) Peptidyl aminodiol renin inhibitors
EP0445206B1 (en) Hydroxamic acid based collagenase inhibitors
AU639212B2 (en) Non-peptide renin inhibitors
AU671724B2 (en) Hydroxamic acid derivatives as metalloproteinase inhibitors
EP0960108B1 (en) Matrix metalloproteinase inhibitors
NO854516L (no) Nye 5-amino-4-hydroksyvalerylderivater.
EP0374098A2 (de) Retrovirale Proteasehemmer
AU624010B2 (en) Peptidyl aminodiol renin inhibitors
US5178877A (en) Encapsulated renin inhibitor composition
IL96942A (he) תערובת רוקחית המכיליה תולדות אמיד מונע רנין
US5276031A (en) Method for treating renal disease
US6265381B1 (en) Orally-active elastase inhibitors
WO1990005531A1 (en) Method for treating vascular diseases
US5258362A (en) Renin inhibiting compounds
FI91159C (fi) Menetelmä imidatsolipitoisten peptidien ja niiden farmaseuttisesti sopivien suolojen valmistamiseksi
IE911326A1 (en) Psoriasis treatment
IE902944A1 (en) Peptidyl difluorodiol renin inhibitors
JPH0686378B2 (ja) 免疫調節剤

Legal Events

Date Code Title Description
RH Patent void